Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bouros (Alexandroupolis, Greece). The management of IPF. Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar

Member's Comments

No comment yet.

Related content which might interest you: IPF Source: Eur Respir Monogr 2017; 77: 58-65 Year: 2017 IPF Source: Eur Respir Monogr 2017; 77: 199-223 Year: 2017 Estimating the effectiveness of pulmonary rehabilitation for different severity of COPD, ILD and IPF Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 IPF - The patients' differential diagnosis of COPD Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: Towards a better diagnosis of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010 The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Source: Eur Respir J 2015; 46: 883-886 Year: 2015 Pulmonary rehabilitation in IPF Source: International Congress 2018 – Interstitial lung disease: an interdisciplinary approach Year: 2018 Patient journey to diagnosis of idiopathic pulmonary fibrosis (IPF) in the US Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 COPD pulmonary rehabilitation - good enough for ILD patients? Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients Year: 2018 Osteoporosis treatment effectiveness in patient with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Pirfenidone treatment for idiopathic pulmonary fibrosis (IPF): a comprehensive analysis of safety Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Therapeutic options and management of pulmonary fibrosis: old and new Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005 Year: 2005 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Pulmonary rehabilitation in COPD and other chronic lung diseases Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Handigrip strenght and dynapenia in patients with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 COPD assessment for symptoms and functional condition in pulmonary rehabilitation Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015